Both insulin resistance and reactive oxygen species (ROS) have been reported to play essential pathophysiological roles in cardiovascular diseases, such as hypertension and atherosclerosis. However, the mechanistic link between ROS, such as H2O2 and insulin resistance in the vasculature, remains undetermined. Akt, a Ser/Thr kinase, mediates various biological responses induced by insulin. In this study, we examined the effects of H2O2 on Akt activation in the insulin-signaling pathway in vascular smooth muscle cells (VSMCs). In VSMCs, insulin stimulates Akt phosphorylation at Ser473. Pretreatment with H2O2 concentration- and time-dependently inhibited insulin-induced Akt phosphorylation with significant inhibition observed at 50 μM for 10 min. A ROS inducer, diamide, also inhibited insulin-induced Akt phosphorylation. In addition, H2O2 inhibited insulin receptor binding partially and inhibited insulin receptor autophosphorylation almost completely. However, pretreatment with a protein kinase C inhibitor, GF109203X (2 μM), for 30 min did not block the inhibitory effects of H2O2 on insulin-induced Akt phosphorylation, suggesting that protein kinase C is not involved in the inhibition by H2O2. We conclude that ROS inhibit a critical insulin signal transduction component required for Akt activation in VSMCs, suggesting potential cellular mechanisms of insulin resistance, which would require verification in vivo.
Get full access to this article
View all access options for this article.
References
1.
Hsueh WA, Law RE. Insulin signaling in the arterial wall. Am J Cardiol84:21J–24J, 1999.
2.
Feener EP, King GL. Vascular dysfunction in diabetes mellitus. Lancet350(Suppl 11):SI9–SI13, 1997.
3.
Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: An update. Hypertension37:1053–1059, 2001.
Westhuyzen J. The oxidation hypothesis of atherosclerosis: An update. Ann Clin Lab Sci27:1–10, 1997.
6.
Nourooz-Zadeh J, Tauaddini-Surmadi J, McCarthy S, Betteridge DJ, Wolff SP. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes44:1054–1058, 1995.
7.
Paolisso G, Giuglianoc D. Oxidative stress and insulin action: Is there a relationship? Diabetologia39:357–363, 1996.
8.
Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res74:1141–1148, 1994.
9.
Folli F, Kahn CR, Hansen H, Bouchie JL, Feener EP. Angiotensin II inhibits insulin signaling and aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest100:2158–2169, 1997.
10.
Alessi DR, Cohen P. Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev8:55–62, 1998.
11.
Downward J. Mechanism and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol10:262–267, 1998.
12.
Kahn B. Type 2 diabetes: When insulin secretion fails to compensate for insulin resistance. Cell92:593–596, 1998.
13.
Eguchi S, Matsumoto T, Motley ED, Utsunomiya H, Inagami T. Identification of an essential signaling cascade for mitogen-activation protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. J Biol Chem271:14169–14175, 1996.
14.
Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem273:8890–8896, 1998.
15.
Inui H, Kitami Y, Kondo T, Inagami T. Transduction of mitogenic activity of platelet-derived growth factor (PDGF) AB by PDGF-beta receptor without participation of PDGF-alpha receptor in vascular smooth muscle cells. J Biol Chem268:17045–17050, 1993.
16.
Lawlor MA, Alessi DR. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci114:2903–2910, 2001.
17.
Fialkow L, Chan CK, Rotin D, Grinstein S, Downey GP. Activation of the mitogen-activated protein kinase signaling pathway in neutrophils. Role of oxidants. J Biol Chem269:31234–31242, 1994.
18.
Wilmer WA, Tan LC, Dickerson JA, Danne M, Rovin BH. Interleukin-1beta induction of mitogen-activated protein kinases in human mesangial cells. Role of oxidation. J Biol Chem272:10877–10881, 1997.
19.
Barthel A, Nakatani K, Dankedar AA, Roth RA. Protein kinase C modulates the insulin-stimulated increase in Akt1 and Akt3 activity in 3T3-L1 adipocytes. Biochem Biophys Res Commun243:509–513, 1998.
20.
Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem268:9194–9197, 1993.
21.
Liao DF, Monia B, Dean N, Berk BC. Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells. J Biol Chem272:6146–6150, 1997.
22.
Rudich A, Kozlovsky N, Potashnik R, Bashan N. Oxidative stress reduces insulin responsiveness in 3T3-L1 adipocytes. Am J Physiol272:E935–E940, 1997.
23.
Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes47:1562–1565, 1998.
24.
Tirosh A, Potashnik R, Bashan N, Rudich A. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J Biol Chem274:10595–10602, 1999.
25.
Wymann MP, Pirola L. Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta1436:127–150, 1998.
26.
Hansen L, Ikeda Y, Olsen G, Busch A, Mosthaf L. Insulin signaling is inhibited by micromolar concentrations of H2O2. J Biol Chem274:25078–25084, 1999.
27.
Li J, De Fea K, Roth RA. Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway. J Biol Chem274:9351–9356, 1999.
28.
De Fea K, Roth RA. Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase. J Biol Chem272:31400–31406, 1997.
29.
De Fea K, Roth R. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. Biochemistry36:12939–12947, 1997.
30.
Motley ED, Kabir SM, Eguchi K, Hicks AL, Gardner CD, Reynolds CM, Frank GD, Eguchi S. Protein kinase C inhibits insulin-induced Akt activation in vascular smooth muscle cells. Cell Mol Biol47:1059–1062, 2001.
31.
Motley ED, Kabir SM, Gardner CD, Eguchi K, Frank GD, Kuroki T, Ohba M, Yamakawa T, Eguchi S. Lysophosphatidylcholine inhibits insulin-induced Akt activation through protein kinase C-alpha in vascular smooth muscle cells. Hypertension39:508–512, 2002.
32.
Motley ED, Eguchi K, Gardner CD, Hicks AL, Reynolds CM, Frank GD, Mifune M, Ohba M, Eguchi S. Insulin-induced Akt activation is inhibited by angiotensin II in the vasculature through protein kinase C-alpha. Hypertension41:775–780, 2003.
33.
Widmann C, Gibson S, Johnson GL. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem273:7141–7147, 1998.
34.
Kim B, Feldman EL. Insulin-like growth factor I prevents mannitol-induced degradation of focal adhesion kinase and Akt. J Biol Chem277:27393–27400, 2002.
35.
Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, Griendling KK. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem274:22699–22704, 1999.
36.
Goetze S, Blaschke F, Stawowy P, Bruemmer D, Spencer C, Graf K, Grafe M, Law RE, Fleck E. TNFalpha inhibits insulin’s antiapoptotic signaling in vascular smooth muscle cells. Biochem Biophys Res Commun287:662–670, 2001.
37.
Jacob A, Molkentin JD, Smolenski A, Lohmann SM, Begum N. Insulin inhibits PDGF-directed VSMC migration via NO/ cGMP increase of MKP-1 and its inactivation of MAPKs. Am J Physiol283:C704–C713, 2002.
